Delivery of antisense peptide nucleic acids to cells by conjugation with small arginine-rich cell-penetrating peptide (R/W)9

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Cordier, Céline ^a,b,c   Boutimah, Fatima ^a,b,c   Bourdeloux, Mathilde ^a,b,c   Dupuy, Florian ^a,b,c   Met, Elisabeth ^a,b,c   Alberti, Patrizia ^a,b,c   Loll, François ^a,b,c   Chassaing, Gérard ^d,e   Burlina, Fabienne ^d,e   Saison Behmoaras, Tula Ester ^a,b,c  

^a MUSÉUM NATIONAL D'HISTOIRE NATURELLE   (France)

^b INSERM   (France)

^c CNRS   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e Centre National de la Recherche Scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLARGINYLTRYPTOPHYLTRYPTOPHYLARGINYLARGINYLTRYPTOPHYLARGINYLARGINE; CELL PENETRATING PEPTIDE; CHLOROQUINE; LYSINE; PEPTIDE NUCLEIC ACID; PROTEOGLYCAN; UNCLASSIFIED DRUG; ANTISENSE OLIGONUCLEOTIDE; ARGININE; GLYCOSAMINOGLYCAN; PEPTIDE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ANTISENSE THERAPY; ARTICLE; CELL ASSAY; CELL PERMEABILIZATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG CONJUGATION; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GENE DELIVERY SYSTEM; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INHIBITION KINETICS; INTERNALIZATION; MALE; MOLECULAR INTERACTION; NONHUMAN; PINOCYTOSIS; SEQUENCE ANALYSIS; AMINO ACID SEQUENCE; ANIMAL; CELL LINE; CHEMISTRY; CHO CELL LINE; CRICETULUS; ENDOSOME; GENETICS; HELA CELL LINE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; NUCLEOTIDE SEQUENCE; VIROLOGY;

AMINO ACID SEQUENCE; ANIMALS; ARGININE; BASE SEQUENCE; CELL LINE; CELL-PENETRATING PEPTIDES; CHO CELLS; CRICETULUS; ENDOSOMES; GENE TARGETING; GLYCOSAMINOGLYCANS; HELA CELLS; HIV INFECTIONS; HIV-1; HUMANS; OLIGONUCLEOTIDES, ANTISENSE; PEPTIDE NUCLEIC ACIDS; PEPTIDES; PINOCYTOSIS;

EID: 84937874688     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104999     Document Type: Article

References (46)

1. Lundin KE, Good L, Strömberg R, Gräslund A, Smith CIE (2006) Biological activity and biotechnological aspects of peptide nucleic acid. Adv Genet 56: 1-51. (Pubitemid 44218735)
2. Nielsen PE (2010) Peptide nucleic acids (PNA) in chemical biology and drug discovery. Chem Biodivers 7: 786-804.
3. Dean DA (2000) Peptide nucleic acids: versatile tools for gene therapy strategies. Adv Drug Deliv Rev 44: 81-95.
4. Lebleu B, Moulton HM, Abes R, Ivanova GD, Abes S, et al. (2008) Cell penetrating peptide conjugates of steric block oligonucleotides. Adv Drug Deliv Rev 60: 517-529. (Pubitemid 351217082)
5. Nielsen PE, Shiraishi T (2011) Peptide nucleic acid (PNA) cell penetrating peptide (CPP) conjugates as carriers for cellular delivery of antisense oligomers. Artif DNA PNA XNA 2: 90-99.
6. Marlin F, Simon P, Saison-Behmoaras T, Giovannangeli C (2010) Delivery of oligonucleotides and analogues: the oligonucleotide conjugate-based approach. Chembiochem 11: 1493-1500.
7. Wadia JS, Stan RV, Dowdy SF (2004) Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis. Nat Med 10: 310-315. (Pubitemid 38667624)
8. Kang SH, Cho MJ, Kole R (1998) Up-regulation of luciferase gene expression with antisense oligonucleotides: implications and applications in functional assay development. Biochemistry 37: 6235-6239.
9. Bendifallah N, Rasmussen FW, Zachar V, Ebbesen P, Nielsen PE, et al. (2006) Evaluation of cell-penetrating peptides (CPPs) as vehicles for intracellular delivery of antisense peptide nucleic acid (PNA). Bioconjug Chem 17: 750-758. (Pubitemid 43794386)
10. Saleh AF, Arzumanov A, Abes R, Owen D, Lebleu B, et al. (2010) Synthesis and splice-redirecting activity of branched, arginine-rich peptide dendrimer conjugates of peptide nucleic acid oligonucleotides. Bioconjug Chem 21: 1902-1911.
11. Abes S, Turner JJ, Ivanova GD, Owen D, Williams D, et al. (2007) Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide. Nucleic Acids Res 35: 4495-4502. (Pubitemid 47244600)
12. Wu RP, Youngblood DS, Hassinger JN, Lovejoy CE, Nelson MH, et al. (2007) Cell-penetrating peptides as transporters for morpholino oligomers: effects of amino acid composition on intracellular delivery and cytotoxicity. Nucleic Acids Res 35: 5182-5191. (Pubitemid 47394201)
13. Madani F, Lindberg S, Langel U, Futaki S, Gräslund A (2011) Mechanisms of cellular uptake of cell-penetrating peptides. J Biophys 2011: 414729.
14. Boutimah-Hamoudi F, Leforestier E, Sénamaud-Beaufort C, Nielsen PE, Giovannangeli C, et al. (2007) Cellular antisense activity of peptide nucleic acid (PNAs) targeted to HIV-1 polypurine tract (PPT) containing RNA. Nucleic Acids Res 35: 3907-3917. (Pubitemid 47244614)
15. Delaroche D, Aussedat B, Aubry S, Chassaing G, Burlina F, et al. (2007) Tracking a new cell-penetrating (W/R) nonapeptide, through an enzyme-stable mass spectrometry reporter tag. Anal Chem 79: 1932-1938. (Pubitemid 46355224)
16. Aubry S, Aussedat B, Delaroche D, Jiao C-Y, Bolbach G, et al. (2010) MALDITOF mass spectrometry: a powerful tool to study the internalization of cellpenetrating peptides. Biochim Biophys Acta 1798: 2182-2189.
17. Fabani MM, Abreu-Goodger C, Williams D, Lyons PA, Torres AG, et al. (2010) Efficient inhibition of miR-155 function in vivo by peptide nucleic acids. Nucleic Acids Res 38: 4466-4475.
18. Torres AG, Fabani MM, Vigorito E, Williams D, Al-Obaidi N, et al. (2012) Chemical structure requirements and cellular targeting of microRNA-122 by peptide nucleic acids anti-miRs. Nucleic Acids Res 40: 2152-2167.
19. De Chaumont F, Dallongeville S, Chenouard N, Hervé N, Pop S, et al. (2012) Icy: an open bioimage informatics platform for extended reproducible research. Nat Methods 9: 690-696.
20. Erbacher P, Roche AC, Monsigny M, Midoux P (1996) Putative role of chloroquine in gene transfer into a human hepatoma cell line by DNA/lactosylated polylysine complexes. Exp Cell Res 225: 186-194. (Pubitemid 26158468)
21. Burlina F, Sagan S, Bolbach G, Chassaing G (2005) Quantification of the cellular uptake of cell-penetrating peptides by MALDI-TOF mass spectrometry. Angew Chem Int Ed Engl 44: 4244-4247. (Pubitemid 40968506)
22. Richard JP, Melikov K, Vives E, Ramos C, Verbeure B, et al. (2003) Cell-penetrating peptides. A reevaluation of the mechanism of cellular uptake. J Biol Chem 278: 585-590. (Pubitemid 36043612)
23. Vercauteren D, Vandenbroucke RE, Jones AT, Rejman J, Demeester J, et al. (2010) The use of inhibitors to study endocytic pathways of gene carriers: optimization and pitfalls. Mol Ther 18: 561-569.
24. Berthault N, Maury B, Agrario C, Herbette A, Sun J-S, et al. (2011) Comparison of distribution and activity of nanoparticles with short interfering DNA (Dbait) in various living systems. Cancer Gene Ther 18: 695-706.
25. Mousavi SA, Malerød L, Berg T, Kjeken R (2004) Clathrin-dependent endocytosis. Biochem J 377: 1-16. (Pubitemid 38114427)
26. Liu AP, Aguet F, Danuser G, Schmid SL (2010) Local clustering of transferrin receptors promotes clathrin-coated pit initiation. J Cell Biol 191: 1381-1393.
27. Khalil IA, Kogure K, Akita H, Harashima H (2006) Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol Rev 58: 32-45.
28. Franco CR, Rocha HA, Trindade ES, Santos IA, Leite EL, et al. (2001) Heparan sulfate and control of cell division: adhesion and proliferation of mutant CHO-745 cells lacking xylosyl transferase. Braz J Med Biol Res 34: 971-975. (Pubitemid 33614033)
29. Aubry S, Burlina F, Dupont E, Delaroche D, Joliot A, et al. (2009) Cell-surface thiols affect cell entry of disulfide-conjugated peptides. FASEB J 23: 2956-2967.
30. Di Guglielmo GM, Le Roy C, Goodfellow AF, Wrana JL (2003) Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat Cell Biol 5: 410-421. (Pubitemid 36592263)
31. El-Andaloussi S, Johansson HJ, Lundberg P, Langel U (2006) Induction of splice correction by cell-penetrating peptide nucleic acids. J Gene Med 8: 1262-1273. (Pubitemid 44660525)
32. Koppelhus U, Awasthi SK, Zachar V, Holst HU, Ebbesen P, et al. (2002) Cell-dependent differential cellular uptake of PNA, peptides, and PNA-peptide conjugates. Antisense Nucleic Acid Drug Dev 12: 51-63. (Pubitemid 34627600)
33. Drin G, Cottin S, Blanc E, Rees AR, Temsamani J (2003) Studies on the internalization mechanism of cationic cell-penetrating peptides. J Biol Chem 278: 31192-31201. (Pubitemid 36994635)
34. Nakase I, Niwa M, Takeuchi T, Sonomura K, Kawabata N, et al. (2004) Cellular uptake of arginine-rich peptides: roles for macropinocytosis and actin rearrangement. Mol Ther 10: 1011-1022. (Pubitemid 39625245)
35. Ivanova GD, Arzumanov A, Abes R, Yin H, Wood MJA, et al. (2008) Improved cell-penetrating peptide-PNA conjugates for splicing redirection in HeLa cells and exon skipping in mdx mouse muscle. Nucleic Acids Res 36: 6418-6428.
36. Hassane FS, Ivanova GD, Bolewska-Pedyczak E, Abes R, Arzumanov AA, et al. (2009) A peptide-based dendrimer that enhances the splice-redirecting activity of PNA conjugates in cells. Bioconjug Chem 20: 1523-1530.
37. Abes S, Williams D, Prevot P, Thierry A, Gait MJ, et al. (2006) Endosome trapping limits the efficiency of splicing correction by PNA-oligolysine conjugates. J Control Release 110: 595-604. (Pubitemid 43163449)
38. Shiraishi T, Pankratova S, Nielsen PE (2005) Calcium ions effectively enhance the effect of antisense peptide nucleic acids conjugated to cationic tat and oligoarginine peptides. Chem Biol 12: 923-929. (Pubitemid 41206806)
39. Koppelhus U, Shiraishi T, Zachar V, Pankratova S, Nielsen PE (2008) Improved cellular activity of antisense peptide nucleic acids by conjugation to a cationic peptide-lipid (CatLip) domain. Bioconjug Chem 19: 1526-1534.
40. Amand HL, Fant K, Nordén B, Esbjörner EK (2008) Stimulated endocytosis in penetratin uptake: effect of arginine and lysine. Biochem Biophys Res Commun 371: 621-.
41. Amand HL, Rydberg HA, Fornander LH, Lincoln P, Nordén B, et al. (2012) Cell surface binding and uptake of arginine- and lysine-rich penetratin peptides in absence and presence of proteoglycans. Biochim Biophys Acta 1818: 2669-2678.
42. Rydberg HA, Matson M, Amand HL, Esbjörner EK, Nordén B (2012) Effects of tryptophan content and backbone spacing on the uptake efficiency of cell-penetrating peptides. Biochemistry 51: 5531-5539.
43. Bechara C, Pallerla M, Zaltsman Y, Burlina F, Alves ID, et al. (2013) Tryptophan within basic peptide sequences triggers glycosaminoglycan-dependent endocytosis. FASEB J 27: 738-749.
44. Rogers FA, Lin SS, Hegan DC, Krause DS, Glazer PM (2012) Targeted gene modification of hematopoietic progenitor cells in mice following systemic administration of a PNA-peptide conjugate. Mol Ther 20: 109-118.
45. Lecosnier S, Cordier C, Simon P, François J-C, Saison-Behmoaras TE (2011) A steric blocker of translation elongation inhibits IGF-1R expression and cell transformation. FASEB J 25: 2201-2210.
46. Briceño E, Calderon A, Sotelo J (2007) Institutional experience with chloroquine as an adjuvant to the therapy for glioblastoma multiforme. Surg Neurol 67: 388-391. (Pubitemid 46365851)